State of the art and recent advance in the treatment of resectable nonmetastatic rectal cancer

Surgical Oncology

Volumn 16, Issue , 2007, Pages 125-128

  Ortholan, C ^a   Gerard, J P ^a   Benezery, K ^a   Francois, E ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

Conservative treatment; Contact X ray; Local control; Radiotherapy; Rectal cancer

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CETUXIMAB; FLUOROURACIL; IRINOTECAN; OXALIPLATIN; TEGAFUR;

ADJUVANT CHEMOTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTINUOUS INFUSION; HUMAN; LAPAROSCOPY; METHODOLOGY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RECTUM CANCER; REVIEW;

CLINICAL TRIALS AS TOPIC; HUMANS; NEOADJUVANT THERAPY; RECTAL NEOPLASMS;

EID: 36649027281     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2007.10.023     Document Type: Review

References (14)

1. Bosset J.F., Collette L., Calais G., et al. Chemotherapy with preoperative radiotherapy in rectal cancer. New England Journal of Medicine 355 (2006) 1114-1123
2. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation.
3. Chau I., Brown G., Cunningham D., et al. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoriadiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. Journal of Clinical Oncology 24 (2006) 668-674
4. Crane C.H., and Sargent D.J. Substitution of oral fluoropyridimidines for infusional fluorouracil with radiotherapy:how much data do we need?. Journal of Clinical Oncology 22 (2004) 2978-2981
5. François Y., Nemoz C.J., Baulieux J., et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter saving surgery for rectal cancer. The Lyon R90.01 randomized trial. Journal of Clinical Oncology 17 (1999) 2396-2402
6. Gérard J.P., Chapet O., Hartweig J., et al., Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy:the lyonR96-02 randomized trial. Journal of Clinical Oncology 22 (2004) 2404-2409
7. Gérard J.P., Conroy T., Bonnetain F., et al. Preoperative radiotherapy with of without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCE 9203. Journal of Clinical Oncology 24 (2006) 4620-4625
8. Habr-Gama A., Perez R.O., Nadalin W., et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy:long-term results. Annales of Surgery 240 (2004) 711-717 (discussion 717-8)
9. Kapiteijn E., Marijnen C.A., Nagtegaal I.D., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. New England Journal of Medicine 345 (2001) 690-692
10. Lezoche E., Guerrieri M., Paganini A.M., et al. Long-term results in patients with T2-3 N0 distal rectal cancer undergoing radiotherapy before transanal endoscopic microsurgery. British Journal of Surgery 92 (2005) 1546-1552
11. MERCURY studio group: Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer:prospective observational study. British Medical Journal 2006: 333:779.
12. Ortholan C., Francois E., Thomas O., et al. Role of radiotherapy with surgery for T3 and resectable T4 rectal cancer:evidence form randomized trials. Diseases of Colon and Rectum 49 (2006) 302-310
13. Sauer R., Becker H., Hohenberger W., et al. Preoperative versus postoperative radiochemotherapy for rectal cancer. New England Journal of Medicine 351 (2004) 7131-7140
14. Sebag-Montefiore D., Steele R., Quirke P., et al. Routine short course pre-op radiotherapy or selective post-op chemoradiotherapy for resectable rectal cancer? Preliminary results of the MCR CR 07 randomized trial. Journal of Clinical Oncology 24 (2006) 148S